Try our beta test site
1550 studies found for:    "Acute lymphoblastic leukemia"
Show Display Options
Rank Status Study
21 Active, not recruiting A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: doxorubicin;   Drug: vincristine;   Drug: methotrexate;   Drug: asparaginase;   Drug: dexamethasone;   Radiation: cranial radiation;   Drug: leucovorin;   Drug: cytarabine;   Drug: hydrocortisone;   Drug: 6-mercaptopurine (6-MP);   Drug: e. coli L-asparaginase
22 Terminated CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta;   Biological: Irradiated donor-derived Lymphoblastoid Cell Line
23 Completed Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors
Condition: Acute Lymphoblastic Leukemia
Intervention: Other: Neurological Examination/Questionnaires
24 Completed The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
25 Recruiting Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Sham;   Other: Cognitive Assessment;   Other: Brain Games Stimulation
26 Completed Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Corticosteroid;   Drug: Rapamycin
27 Terminated Treatment of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase (E. Coli);   Drug: asparaginase (Erwina);   Drug: dexrazoxane;   Drug: doxorubicin;   Procedure: cranial radiation (once daily fractionation);   Procedure: cranial radiation (twice-daily fractionation);   Procedure: Intrathecal chemotherapy without radiation
28 Unknown  Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia
Condition: Adult Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine Sulfate Liposome;   Drug: Vincristine Sulfate
29 Completed STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Imatinib
30 Completed Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: bortezomib (Velcade);   Drug: dexamethasone;   Drug: PEG-asparaginase;   Drug: doxorubicin;   Drug: cytarabine;   Drug: methotrexate;   Drug: vincristine
31 Recruiting Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Blinatumomab;   Procedure: Hematopoietic Cell Transplantation
32 Active, not recruiting CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: CMC-544 (Inotuzumab Ozogamycin);   Drug: Rituximab
33 Completed A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: clofarabine
34 Suspended Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Liposomal cytarabine;   Drug: Intrathecal triple
35 Completed Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Collection of treatment-stratefying prognostic factors
36 Recruiting ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: PEG Asparaginase at six weeks interval;   Drug: PEG Asparaginase at two weeks interval
37 Completed Treatment of Older Adults With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: PEG-asparaginase;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Imatinib;   Drug: Clofarabine;   Drug: 6 Mercaptopurine
38 Withdrawn Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
39 Active, not recruiting Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Clofarabine, Cyclophosphamide
40 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.